Korea Medical Institute honored for advancing global health care
The Global Healthcare Merit Award honors individuals and organizations that have made significant contributions to expanding Korean medical services, attracting international patients, training foreign medical professionals, and enhancing Korea's global medical reputation.
In celebration of its 40th anniversary, KMI was recognized for its efforts in promoting Korea's medical checkup system abroad and improving international health care services through its extensive global network.
KMI also participated in the Korea Health Industry Development Institute's medical overseas expansion project in 2024 and successfully established a Korean-style medical checkup center in Ulaanbaatar, Mongolia.
'It is a great honor to be recognized for our contribution to the advancement of global health care on behalf of Korea's checkup institutions,' said KMI Chairman Lee Kwang-bae.
'We will continue to build trust with our global patients and promote the excellence of Korea's medical checkup system worldwide.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
6 hours ago
- Korea Herald
Lee to meet Bill Gates to discuss global health issues, collaboration
President Lee Jae Myung plans to meet Bill Gates, chair of the Gates Foundation and Microsoft Corp. co-founder, in Seoul on Thursday, the presidential office said Wednesday. Gates, who has spearheaded initiatives on climate change, poverty reduction and global health through the foundation, is visiting South Korea to reportedly explore cooperation with Korean pharmaceutical companies on a vaccine supply project for low-income countries. During the meeting at the presidential office, the two are expected to discuss global health issues and potential collaboration in the sector, according to officials. (Yonhap)
Korea Herald
13-08-2025
- Korea Herald
Korea urges measles vaccination before overseas travel as imported cases rise
Amid a sharp rise in imported cases of measles recently, the Korea Disease Control and Prevention Agency has urged travelers to ensure they are fully vaccinated against the infectious disease before going abroad. According to KDCA data released Wednesday, 68 cases of measles had been confirmed in Korea as of Aug. 9, since the government began to closely observe outbreak cases in December 2024. The number of cases observed most recently was a 1.4-fold increase from the number of cases recorded over the same period a year prior. Of the total number of cases, 49 — 72.1 percent — were infections contracted overseas and detected after entry. A majority of the cases, adding up to 42 in total, were found to be contracted from Vietnam, followed by South Africa, Uzbekistan, Thailand, Italy and Mongolia. The nineteen other domestic cases were also linked to these imported infections, with transmission occurring in households and medical facilities with measles patients. Adults made up a majority of the cases, with 77.9 percent of patients aged 19 or older. Notably, 54.4 percent were either unvaccinated against measles or were unsure of their vaccination status. Citing data from the World Health Organization, the KDCA said some 360,000 measles cases were reported globally in 2024, with outbreaks still continuing to be observed into this year in Europe, the Middle East, Africa and Southeast Asia — regions all frequented by Korean travelers. According to the agency, lower vaccination rates for measles worldwide have fueled the resurgence. Due to the COVID-19 pandemic, measles vaccinations were disrupted due to a strain in the health care system as well as lockdowns that made it difficult for some families to access vaccination services. In 2023, the global rate of the second-dose measles vaccination — which is crucial for full immunity — was 74 percent, below the WHO-recommended 95 percent. To stay safe from measles infections, the KDCA has advised travelers to measles-affected countries to complete the two-dose measles, mumps and rubella vaccine. Those developing a fever or a rash within three weeks of returning to South Korea from a measles-affected country should wear a mask, minimize contact with others and inform medical authorities of recent travel before seeking care. Extra caution is urged for households with infants too young for vaccination, pregnant women and those with weakened immune systems.
Korea Herald
13-08-2025
- Korea Herald
HLB appoints Brian Kim as CEO of US subsidary Elevar Therapeutics
Korean biopharmaceutical firm HLB said Wednesday it has appointed Brian Kim, current CEO of HLB Innovation and Verismo Therapeutics, as CEO of its US subsidiary, Elevar Therapeutics. Kim will lead all three companies concurrently. HLB said the leadership change is a strategic move to align with the skills needed at each stage of drug development, particularly as Elevar prepares to enter the commercialization phase and expand global partnerships with big pharma. Kim holds extensive experience in finance, strategic business management and biotechnology, including research in CAR-T cancer treatments and founding multiple biotech firms. A former tenured clinical professor at the University of Pennsylvania School of Dental Medicine, Kim was a founding member of Nasdaq-listed Inovio Pharmaceuticals. He has invested in various businesses, including acquiring a Kospi-listed company and elevating it into the Kospi 200 index. Kim also has invested in and led several biotech ventures in both the US and Korea. 'I feel a deep sense of responsibility taking on this role at such a pivotal moment,' Kim said. 'My focus will be on securing regulatory approval for Elevar's lead liver cancer therapy and ensuring its successful commercialization, while driving sustainable growth for the company.' HLB added that Kim's leadership will help accelerate Elevar's global business expansion and innovation in oncology therapeutics.
